POLD1 and neoplasm: MMR deficiency alone increases the mutation rate, represents an advantageous genotype and could be fixed during tumor development; however, after a clonal expansion of dMMR, POLD1 exonuclease mutations will further increase the mutation rate by an order of magnitude (Fig. 3G) and thus, should also cause positive selection.